This inventor holds 4 USPTO granted patents. Top assignees: Chembiomed, Ltd., Canadian Patents & Development Ltd., National Research Council of Canada. Active years: 1979-1991.
Company Filing History:
2 out of 17 
1 out of 424 
1 out of 1,039 Years Active: 1979-1991
Title: The Innovative Contributions of David R. Bundle
Introduction
David R. Bundle, an esteemed inventor based in Ottawa, Canada, has made notable advancements in the field of immunology through his innovative patents. With a total of four patents to his name, Bundle's research has significantly enhanced the diagnostic methods for brucellosis and related infections.
Latest Patents
Among his latest patents, Bundle has developed an immunoassay that provides a reliable method for differentiating cattle that have been vaccinated against those that are infected with Brucella spp. This method uses a purified polysaccharide derived from B. abortus and other cross-reacting organisms, leading to improved differentiation of vaccinated and infected animals. Additionally, he has worked on antigenic polysaccharides specific to Brucella abortus and Yersinia enterocolitica. This innovative work allows for easier isolation of the antigen from Yersinia, which can be further modified for use in various immunoassay applications, such as ELISA and RIA. His patents also include procedures and kits for conducting these assays effectively.
Career Highlights
Throughout his career, David R. Bundle has joined forces with reputable companies such as Chembiomed Ltd. and Canadian Patents & Development Ltd. His dedication to research and development in immunology has not only contributed to the scientific community but has also provided practical solutions that impact animal health positively.
Collaborations
Bundle has collaborated with distinguished colleagues, including Raymond U. Lemieux and Donald A. Baker. Their combined expertise has led to fruitful developments in immunological research and patent applications, enriching the field and providing valuable resources for future studies.
Conclusion
David R. Bundle's innovative work in immunoassays represents a significant leap forward in the ability to identify and differentiate cases of brucellosis. His patents are a testament to his commitment to improving diagnostic methods in the field of veterinary medicine. With ongoing research and collaboration, Bundle continues to be a vital contributor to the area of immunology and a beacon for future inventions.